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Colorectal surgeryAbstract Background: Laparoscopic colectomy has been shown to have signiﬁcant short- and
long-term beneﬁts compared to open approach. The incorporation of laparoscopy in developing
countries is challenging, due to the high costs of equipment and lack of expertise. The aim of this
study was to evaluate the safety and feasibility of laparoscopic colorectal surgery for cancer that
could be performed in developing countries under different circumstances in developed countries.
Methods: Thirty-seven patients (23 males and 14 females) with colorectal cancer with a median age
of 46 years (39–72) have been enrolled for laparoscopic colo-rectal surgery in a tertiary center in
Egypt (South Egypt Cancer Institute) with the trend of reuse of some disposable laparoscopic
instruments.
Results: The median operative time was 130 min (95–195 min). The median estimated blood loss
was 70 ml (30–90 ml). No major intra-operative complications have been encountered. Two cases
(5.5%) have been converted because of local advancement (one case) and bleeding with unavailabil-
ity of vessel sealing device at that time (one case). The median time for passing ﬂatus after surgery
was 36 h (12–72 h). The median hospital stay was 4.8 days (4–7 days). The peri-operative period
passed without events. Pathologic outcome revealed that the median number of retrieved lymph
nodes was 14 (range 9–23 lymph node) and all cases had free surgical margin.
Conclusion: Laparoscopic colorectal surgery for cancer in developing countries could be safe and
feasible. Safe reuse of disposable expensive parts of some laparoscopic instruments could help in
propagation of this technique in developing countries.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of National Cancer Institute,
Cairo University. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1a Patient positioning and ports distribution for right
hemicolectomy.
Figure 1b Patient positioning and ports distribution for left
hemicolectomy and recto-sigmoid resection.
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Background
Laparoscopic colectomy has been shown to have signiﬁcant
short- and long-term beneﬁts compared with the open
approach [1–5]. Despite the evidence from multiple, prospec-
tive, randomized trials, the adoption rate of laparoscopic
colectomy has been reported to be low. In a recent study by
Robinson et al., of all colorectal surgeries performed in high
volume hospitals, only 7.3% have been performed using mini-
mal invasive surgery (MIS). They found a signiﬁcant socioeco-
nomic disparity in the use of MIS [6].
The incorporation of laparoscopic techniques in developing
countries has been challenging, due in particular to the high
costs of equipment and lack of expertise [7]. However; many
laparoscopic procedures, including appendectomy, cholecys-
tectomy, hysterectomy and splenectomy have been successfully
performed in developing countries [8–10].
Demonstrating oncologic outcomes similar to those
achieved in a developed setting will further support and
encourage the continued growth of laparoscopy for cancer in
developing countries [2,11–14]. There are currently limited
data referring to the surgical safety and the oncologic feasibil-
ity of laparoscopic colorectal surgery for cancer in the situa-
tion of limited equipment in developing settings [15].
Therefore, the aim of this study was to evaluate the safety
and feasibility of laparoscopic colorectal surgery for cancer
that could be performed under different circumstances in
developed countries in a tertiary center in Egypt as an example
of developing countries.
Patients and methods
This is a feasibility and safety, phase I/II clinical non random-
ized study. The study was conducted at South Egypt Cancer
Institute, Assiut University, Egypt. Thirty-seven patients (23
males and 14 females) have been enrolled for laparoscopic
colo-rectal surgery for colorectal cancer in the period of
March 2011 to March 2014. The diagnosis of colorectal cancer
was conﬁrmed with colonoscopy and biopsy. Preoperative
workup has included blood tests, chest X-ray and serum car-
cino-embryonic antigen (CEA). CT pelvic-abdominal scan
was a routine. The study was approved by the ethics committee
at South Egypt Cancer Institute. The surgical approach was
decided with the consent of the patients after a thorough dis-
cussion on the advantages and risks of the approach.
Inclusion criteria were histologically proven carcinoma of
the colon or upper half of the rectum, T1 to T3 tumors accord-
ing to TNM classiﬁcation, no evidence of extra-colonic or
extra-rectal extension or distant metastasis by means of CT,
abdominal ultrasound and postero-anterior chest radiograph.
Patients with large, ﬁxed tumors with invasion to other organs
or patients with distant metastasis were excluded from the
laparoscopic trial.
The patients have received mechanical bowel preparation
the day before surgery and prophylactic intravenous antibi-
otics were administered at the time of induction of anesthesia.
A urinary catheter was inserted after the patient was put under
general anesthesia. Naso-gastric tube was not used as a
routine.The patients were placed in a supine head down position for
right hemi-colectomy and lithotomy with head down position
for left hemi-colectomy and sigmoidectomy.
For economic causes, we usually use reusable laparoscopic
instruments. For disposable instruments, we reuse it several
times after proper sterilization, provided that it works efﬁ-
ciently. The only disposable laparoscopic instrument that has
been used for several times in this study was the vascular seal-
ing device. All other surgical instruments used in this study
were reusable.
At the beginning of the procedure, the peritoneal cavity was
accessed through an insufﬂations’ needle and carbon dioxide
was insufﬂated to maintain the intra-abdominal pressure at
10–12 mmHg. For all cases, trans-umbilical 10 mm port was
used for the camera. For right colon cancer another 2 to 3
ports of either 5 or 10 mm size were positioned so that conve-
nient and safe dissection could be done as shown in Fig. 1a.
For left colon and recto-sigmoid cancer, the ports were placed
as in Fig. 1b. Dissection was performed in the majority of
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sealing devices. Vessels were controlled with bipolar vascular
sealing device or absorbable clips intra-corporeally in most cir-
cumstances. Following bowel mobilization and vessel division,
the tumor-bearing segment was retrieved through an incision
(4–5 cm long) at a convenient site. In case of a right sided colo-
nic lesion, resection and anastomosis were performed extra-
corporeally by interrupted hand sutures. Colorectal or coloa-
nal anastomosis was performed by hand suturing or using a
circular stapler which was inserted trans-anally. Colorectal
mobilization and resection followed the same principles as in
open surgery.
Conversion was deﬁned as the need for making the abdomi-
nal incision for bowel mobilization and/or vascular control.
Operative mortality was deﬁned as death that occurred during
the same hospital stay or within 30 days following the primary
operation. Operative morbidities were deﬁned as com-
plications that resulted in prolonged hospital stay or additional
interventions or procedures [14].
Data collection and statistical analysis
Data on the patient’s demographics, medical comorbidities,
location of the tumors, operative details, postoperative out-
comes, and follow up status were collected prospectively and
entered into a data base. The data were described as median
and range.
Results
In the period of March 2011 till March 2014, 37 cases (23
males and 14 females) of colorectal cancer have been enrolled
for laparoscopic colorectal resection. The mean age was
47 years (39–72) and the average body mass index (BMI)
was 29 (26–33.5).
Right hemicolectomy was performed for 9 cases. Left hemi-
colectomy with sigmoidectomy was performed for 11 cases of
proximal sigmoid cancer and anterior resection was done for
14 cases of recto-sigmoid cancer. Total colectomy with ileo-
rectal anastomosis was performed for one case of cecal cancer
on top of familial adenomatous polyposis coli (FAP). Two
cases (5.5%) have been converted because of locally advanced
stage (one case) and bleeding with unavailability of vessel seal-
ing device (one case) (Table 1).
The median operative time for unconverted cases was
125 min (95–195). The median estimated blood loss was
70 ml (30–90 ml). No major intra-operative complications
have been encountered. The median time for passing ﬂatusTable 1 Surgical procedures and lesions’ distribution.
Procedure Lesion Number %
1. Rt. hemicolectomy Cecal 5/37 13.5
Rt. colon 2/37 5.5
Hepatic ﬂexure 2/37 5.5
2. Lt. hemicolectomy with
sigmoidectomy
Proximal
sigmoid
11/37 30
3. Anterior resection Rectosigmoid 14/37 37.5
4. Total colectomy FAP with cecal
cancer
1/37 2.7
5. Conversion 2/37 5.5after surgery was 36 h (12–72 h). The median hospital stay
was 5 days (4–7 days). The peri-operative period passed with-
out events.
Pathologic outcome revealed that the median number of
retrieved lymph nodes was 17 (range 9–23 lymph node) and
all cases have free surgical margin.
The median number of reuse of the vascular sealing device
was 5 times (4–7 times) and the estimated reduction in its cost
in comparison to single use was 80% including sterilization
cost. This means that the cost for every case was reduced by
560 USD.
Discussion
The present study provides further evidence regarding the
oncologic feasibility and surgical safety of laparoscopic colo-
rectal surgery in developing countries.
For the patients of colorectal cancer in developing countries
to get the beneﬁts of the MIS, we believe that safe reuse of dis-
posable laparoscopic instruments should be considered. In our
experience we used for example the most recently introduced
vessel sealing bipolar devices. However, for economic issues
we safely re-used its disposable parts several times. We know
that, the surgeon has the responsibility of determining the
functional integrity of any surgical instrument before its use
[16]. Under carefully monitored conditions and strict guide-
lines, reuse of disposable laparoscopic instruments can be
cost-effective [16,17]. Several times reuse of the vascular seal-
ing devices, has reduced its cost by about 80% that means
560 USD at the time of the study which is a good ﬁnancial
beneﬁt regarding Egypt economy.
The experience accumulated in our institution over 3 years
with mixed use of disposable and reusable laparoscopic instru-
ments demonstrates that reuse of disposable laparoscopic
instruments could be economical. The judicious choice of dis-
posable and reusable instruments could provide the best possi-
ble tools for the surgeons in developing countries to perform
laparoscopic procedures provided that patient safety and
oncologic feasibility could be maintained [17,18].
Introducing laparoscopy for cancer into developing coun-
tries with its advantages that have been established in devel-
oped countries and at the same time as an economically
acceptable procedure, could aid in its spread so that patients
in developing countries can get its beneﬁts [2,11–14].
In Egypt, because of limited resources and the expenses of
MIS, laparoscopic colorectal surgery is restricted in use for a
few tertiary centers with only few cases being treated every
year. For our knowledge, this is the ﬁrst study that evaluates
the current practice of laparoscopic colorectal surgery in
Egypt addressing the issue of reuse of disposable laparoscopic
instruments. The results of this study have showed that we
could perform successfully various types of laparoscopic
colo-rectal surgery for cancer in 35 of 37 cases (right hemi-
colectomy, left hemicolectomy or anterior resection).
We included cases of recto-sigmoid cancers because some
studies show that the pattern of recurrence and survival of
patients with upper rectal cancer were similar to those of sig-
moid cancer and technically anterior resection for upper rectal
cancer does not differ signiﬁcantly from surgery for a sigmoid
cancer [19]. For most of the cases, dissection and mobilization
were performed in a medial to lateral fashion.
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(BMI) of 29 (26–33.5). Laparoscopic colectomy is safe and fea-
sible in patients with high BMI, with no signiﬁcant difference
in recovery of intestinal function and length of hospital stay
compared to patients with normal BMI [20,21].
Operative morbidity is a very important issue, in this series
the mean operative time was 110 min and the mean estimated
blood loss was 70 ml which are similar to other series [14,15].
Only one case has been converted because of bleeding and
unavailability of vascular sealing device, fortunately, this case
was early in this study, therefore after that case and to avoid
conversion, we have provided a new instrument in operative
room so that it can be used if the reused instrument failed to
work during surgery.
In comparison to other studies, patients with laparoscopic
resection in our series had similar short duration of ileus and
early resumption of diet [14,15]. The hospital stay was also sig-
niﬁcantly short. Although we did not experience tremendous
pressure for a short hospital stay and early discharge, the med-
ian hospital stay for our patients with laparoscopic resection
was 5 days. Our series had very similar short term results com-
pared to those of North American and other large multi-center
trials and the meta-analysis of randomized control trials. These
trials showed that signiﬁcant early beneﬁts measured as less
surgical complications, less intra-operative blood loss and less
narcotic use can be achieved with laparoscopy. The meta-
analysis also noted a signiﬁcantly short time to ﬁrst bowel
movement and discharge from hospital [1,22–26].
Dissection through small incision, precise dissection helped
by magniﬁcation and avoidance of visceral handling could be
helping in early recovery of gut function [1,26]. In our study,
there was no evidence of deep venous thrombosis or pul-
monary complications except for one case with hypertension
and diabetes. This might be because of early ambulation and
less postoperative pain. All these factors have contributed to
the short post-operative hospital stay.
We believe that, the most important detail in cancer surgery
is to respect the oncologic principals. In this series, the median
number of retrieved lymph nodes was 14 which is consistent
with the minimum of 12 lymph nodes required for accurate
staging [26]. All cases have negative surgical margin.
Therefore our pathological results were similar to most of
the large trials [1,26].
In conclusion, laparoscopic colectomy for cancer in devel-
oping countries could be safe and feasible and gives similar
results for those of multicenter trials. Safe reuse of disposable
expensive parts of some laparoscopic instruments could help in
propagation of this technique in developing countries. Long
term follow up as well as comparative studies with open sur-
gery are required.
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